Trojan.JS.Iframe.aeq
Threat Scorecard
EnigmaSoft Threat Scorecard
EnigmaSoft Threat Scorecards are assessment reports for different malware threats which have been collected and analyzed by our research team. EnigmaSoft Threat Scorecards evaluate and rank threats using several metrics including real-world and potential risk factors, trends, frequency, prevalence, and persistence. EnigmaSoft Threat Scorecards are updated regularly based on our research data and metrics and are useful for a wide range of computer users, from end users seeking solutions to remove malware from their systems to security experts analyzing threats.
EnigmaSoft Threat Scorecards display a variety of useful information, including:
Ranking: The ranking of a particular threat in EnigmaSoft’s Threat Database.
Severity Level: The determined severity level of an object, represented numerically, based on our risk modeling process and research, as explained in our Threat Assessment Criteria.
Infected Computers: The number of confirmed and suspected cases of a particular threat detected on infected computers as reported by SpyHunter.
See also Threat Assessment Criteria.
| Threat Level: | 90 % (High) |
| Infected Computers: | 15 |
| First Seen: | August 20, 2013 |
| Last Seen: | May 22, 2023 |
| OS(es) Affected: | Windows |
Trojan.JS.Iframe.aeq is a Javascript Trojan that diverts the attacked PC user to the harmful websites by generating an iframe. The harmful website carries a malevolent code, which is found as Trojan.JS.Iframe.aeq. Most of the damaging websites are hosted in Spain. The redirect won't return the target computer user the code under some conditions. The first condition is not to access the website twice from the same IP. The second condition - redirect is for the exploit kit website with an unique ID.
Submit Comment
Please DO NOT use this comment system for support or billing questions. For SpyHunter technical support requests, please contact our technical support team directly by opening a customer support ticket via your SpyHunter. For billing issues, please refer to our "Billing Questions or Problems?" page. For general inquiries (complaints, legal, press, marketing, copyright), visit our "Inquiries and Feedback" page.